Get startedLog in
    Picture of CStone Pharmaceuticals logo

    2616 — CStone Pharmaceuticals Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for CStone Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-2,308-1,221-1,920-903-367
    Depreciation
    Amortisation
    Non-Cash Items980512349173-141
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital23618664.572.6-139
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-1,081-508-1,484-612-589
    Capital Expenditures-10.4-71.4-149-102-65
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-6481,252-677467685
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-6591,181-827365620
    Financing Cash Flow Items-102-1.32-2.24-11.8-13.5
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities2,0911,38992.328.5388
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash4251,898-2,282-184438